10-Q Q1 2019

Company

Denali Therapeutics Inc.

Filed

May 8, 2019

Period of Report

March 31, 2019

Accession Number

0001714899-19-000032

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →